Cardiac Surgery

Cardiothoracic surgery includes coronary artery bypass surgery (CABG), heart valve repair or replacement, left ventricular assist device (LVAD) placement, heart transplant, assisting in minimally invasive transcatheter valve structural heart procedures such as TAVR, left atrial appendage (LAA) occlusion, septal myectomy, surgical ablation for arrhythmias, and reconstruction of the heart in congenial heart disease cases. 

Thumbnail

Blood pressure drug recalled due to black contaminants—FDA highlights safety risks

The recall was put in place after a customer discovered “visible black particulate matter” in a sealed vial. If the contaminant enters a patient's blood vessels, it could lead to serious complications, including a stroke or even death. 

A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon

SAVR/CABG vs. TAVR/PCI: Key differences when heart patients present with severe AS and CAD

Surgery offers multiple long-term benefits when compared to a more interventional approach, though it is still associated with certain risks of its own. In the end, researchers agree, the decision is one that should involve input from surgeons, cardiologists and others.

Gilbert Tang, MD, explains how new transcatheter tricuspid options will help drive surgical volume growth. #TTVR

New transcatheter tricuspid treatment options poised to drive surgical volume growth

Gilbert Tang, MD, explains how transcatheter tricuspid TEER and total valve replacement options will likely lead to higher tricuspid valve surgical volumes in the years ahead.

Newsweek ranked the 50 best heart hospitals in the world

Young SAVR patients live longer with mechanical valves—should surgeons, cardiologists rethink current practice?

Bioprosthetic valves are being used more and more for aortic valve replacement, but mechanical valves appear to provide better long-term outcomes for patients 60 and younger. The new study, based on data from nearly 110,000 patients, was presented at STS 2025 and published in the Journal of the American College of Cardiology.

The Society of Thoracic Surgeons (STS) has elected Joseph F. Sabik III, MD, a veteran cardiac surgeon with the University Hospitals (UH) Harrington Heart & Vascular Institute, to be its new president. Sabik officially began his one-year term Sunday, Jan. 26, during STS 2025, the group’s annual meeting.

Veteran heart surgeon elected STS president

Cardiac surgeon Joseph F. Sabik III, MD, is an established clinical researcher and has held several committee positions with STS over the years.

Thumbnail

Heart transplant patients on Medicaid face a higher risk of major complications

In addition, researchers noted, five-year mortality was inferior for patients on Medicaid when compared to patients with any other type of insurance. 

King Faisal Specialist Hospital and Research Center perform LVAD implant with robotic assistance

Surgeons make history again with world’s first robotic implant of Abbott heart device

The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.

STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.